Journal of Clinical Oncology | 2021
Circulating tumor DNA in identifying resistant subclones post EGFR blockade: Implications for EGFR rechallenge.
Abstract
131Background: For patients with metastatic RAS/RAF wild-type refractory colorectal cancer anti-EGFR therapy can be reused in subsequent lines of therapy. However, it is not entirely clear if all p...